Back to Search
ALDEN SACCO, MD, MPH
MD, MPH
Family Medicine Physician
NPI: 1780212555IndividualAccepts Medicare
Specialties, Licenses & Credentials
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
2025-02219(NC)
Hospitalist Physician
Hospitalist
Code: 208M00000X
MD27321(ME)
Education
UNIVERSITY OF VERMONT COLLEGE OF MEDICINE
Class of 2020
Research & Publications (20)
Identification of copy number abnormalities and inactivating mutations in two negative regulators of nuclear factor-kappaB signaling pathways in Waldenstrom's macroglobulinemia.
PMID 19351844·Cancer Res·2009
8-other
Intrinsic porosity of calcium phosphate cements and its significance for drug delivery and tissue engineering applications.
PMID 19357005·Acta Biomater·2009
8-other
Target populations and relevant therapeutic end points to further improve outcomes in NSTEACS patients.
PMID 19371201·Future Cardiol·2009
6-review
Differential signaling activation by insulin and insulin-like growth factors I and II upon binding to insulin receptor isoform A.
PMID 19443570·Endocrinology·2009
7-preclinical
Novel therapeutic agents in Waldenström's macroglobulinemia.
PMID 19362982·Clin Lymphoma Myeloma·2009
6-review
MicroRNAs 15a and 16 regulate tumor proliferation in multiple myeloma.
PMID 19401561·Blood·2009
7-preclinical
RhoA and Rac1 GTPases play major and differential roles in stromal cell-derived factor-1-induced cell adhesion and chemotaxis in multiple myeloma.
PMID 19443661·Blood·2009
7-preclinical
Advanced squamous cell carcinoma of the oropharynx: efficacy of positron emission tomography and computed tomography for determining primary tumor response during induction chemotherapy.
PMID 19189338·Head Neck·2009
3-trial
Role of proteasome inhibition in Waldenström's macroglobulinemia.
PMID 19362985·Clin Lymphoma Myeloma·2009
6-review
CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.
PMID 19139079·Blood·2009
7-preclinical
microRNA expression in the biology, prognosis, and therapy of Waldenström macroglobulinemia.
PMID 19074725·Blood·2009
4-observational
Increased incidence of transformation and myelodysplasia/acute leukemia in patients with Waldenström macroglobulinemia treated with nucleoside analogs.
PMID 19064987·J Clin Oncol·2009
8-other
Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia.
PMID 18981296·Blood·2009
8-other
Internal carotid artery fibromuscular dysplasia in arterial hypertension: management in clinical practice.
PMID 18825547·Blood Press·2008
5-case
Self-renewal and expansion of single transplanted muscle stem cells.
PMID 18806774·Nature·2008
7-preclinical
The HMG-CoA inhibitor, simvastatin, triggers in vitro anti-tumour effect and decreases IgM secretion in Waldenstrom macroglobulinaemia.
PMID 18537966·Br J Haematol·2008
8-other
[Diagnosis and treatment of non-ST-elevation acute coronary syndromes. Common clinical lessons and a few differences between the ESC and the ACC/AHA guidelines published in 2007].
PMID 18678223·G Ital Cardiol (Rome)·2008
4-observational
Rectangle tongue template for reconstruction of the hemiglossectomy defect.
PMID 18794446·Arch Otolaryngol Head Neck Surg·2008
8-other
[Workers with alcohol and drug addiction problems. Consensus Document of the Study Group on Hazardous Workers].
PMID 19248471·Med Lav·2008
6-review
SDF-1/CXCR4 and VLA-4 interaction regulates homing in Waldenstrom macroglobulinemia.
PMID 18448868·Blood·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1021 MOREHEAD MEDICAL DR STE A
CHARLOTTE, NC 28204 - Phone
- (980) 442-2500
Quick Facts
- NPI
- 1780212555
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 6
- Publications
- 20
Are you this provider?
Claim Your Profile